Have a Topic Idea?

What would you like to see featured on MedConnect? Let us know.

Submit an Idea

Drug Information Update- Mavyret (glecaprevir/pibrentasvir)

Mavyret (glecaprevir/pibrentasvir) New Drug Approval: On August 3, 2017 the FDA approved Mavyret for the treatment of adult patients with chronic...

Drug Information Update- Vosevi (sofosbuvir/velpatasvir/voxilaprevir)

Vosevi ( sofosbuvir/velpatasvir/voxilaprevir ) New Drug Approval: On July 18 th , 2017 the FDA approved Vosevi for the treatment of adult patients...

National Drug Take Back Day Yields 450 TONS of Unused Medications

Rise in Prescription Waste is Costing Unnecessary Money Saturday, April 29 was Drug Take Back Day, where unused drugs were returned in droves to designated Drug...

Examining Drug Trend: Hepatitis C

Top 10 Classes - What is Driving Drug Trend Drug price is driving trend. Overall utilization for the top 10 therapeutic classes in 2016 decreased, while prices...

Examining Drug Trend: Oncology

Top 10 Classes - What is Driving Drug Trend Drug price is driving trend. Overall utilization for the top 10 drug classes in 2016 decreased, while prices increased....

Examining Drug Trend: Inflammatory Disease

Drug price is driving trend. Overall utilization for the top 10 drug classes in 2016 decreased, while prices increased. To better understand 2016 trend, we will be...

Industry Trends: The Move to Preferred Networks

Major PBMs are moving toward creating alternative pharmacy networks by moving out one major retail chain (such as CVS or Walgreens) from their in-network coverage. The...

Drug Information Update- Ingrezza (valbenazine)

Ingrezza (valbenazine) New Drug Approval: On April 11 th , 2017, the FDA approved Ingrezza (valbenazine) for the treatment of adults with tardive...

Examining Drug Trend: Diabetes

Drug price is driving trend. Overall utilization for the top 10 drug classes in 2016 decreased, while prices increased. To better understand 2016 trend, we will be...

Drug Information Update- Dupixent (dupilumab)

Dupixent (dupilumab) New Drug Approval: On March 13 th , 2017 the FDA approved Dupixent (dupilumab) for the treatment of adult patients with...

Drug Information Update- Ocrevus (ocrelizumab)

Ocrevus (ocrelizumab) New Drug Approval: On March 28 th , 2017 the FDA approved Ocrevus (ocrelizumab) to treat adult patients with relapsing forms of...

Drug Information Update- Kisqali (ribociclib)

Kisqali (ribociclib) New Drug Approval: On March 13 th , 2017 the FDA approved Kisqali (ribociclib) in combination with an aromatase inhibitor as initial...

Drug Inflation in the News: EpiPen

With drug inflation at the forefront of trend concerns in the pharmacy benefit industry, the rise in cost of drugs like the EpiPen have gained lots of press coverage in...

How Blockbuster Drugs are Shaping Drug Inflation

With the cost of certain medications rising rapidly, it’s no surprise that many plan sponsors are feeling the financial impact of price increases associated with drug...

5 Reasons You Won’t Want to Miss The MedImpact Annual Conference

  The MedImpact conference is only 5 weeks away! Don’t miss out on the opportunity to hear from industry experts on all the hot topics affecting...

Biosimilars: The Challenges and The Opportunities

Biosimilar drugs present a large potential for reducing specialty spending, but their instability and sensitivity to manufacturing present challenges as well. Biosimilars...

Drug Information Update- Basaglar (insulin glargine)

New Drug Approval - Basaglar (insulin glargine) FDA Approval: In December 2015, the FDA approved Basaglar (insulin glargine), a long-acting human insulin...

Combating Opioid Waste and Abuse

Opioids are now the leading cause of accidental death in the U.S . According to the Center for Disease Control (CDC), there were a total of 47,055 lethal drug overdoses...